Terug
Dagbereik
€ 70,67
€ 71,85
52-Weeksbereik
€ 57,65
€ 89,77
Volume
5.974.726
50D / 200D Gem.
€ 79,49
/
€ 76,90
Vorige Slotkoers
€ 71,65
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 15,5 | 0,3 |
| P/B | 3,1 | 2,9 |
| ROE % | 22,1 | 3,7 |
| Net Margin % | 10,1 | 3,8 |
| Rev Growth 5Y % | 4,1 | 10,0 |
| D/E | 1,0 | 0,2 |
Koersdoel Analisten
Hold
€ 91,70
+29.2%
Low: € 77,00
High: € 105,00
Forward K/W
14,1
Forward WPA
€ 5,07
WPA Groei (sch.)
+0,0%
Omzet Sch.
22 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 7,11
€ 6,93 – € 7,24
|
25 B | 2 |
| FY2028 |
€ 6,23
€ 5,80 – € 6,97
|
24 B | 7 |
| FY2027 |
€ 5,60
€ 5,28 – € 5,74
|
23 B | 14 |
Belangrijkste Punten
Revenue grew 4,07% annually over 5 years — modest growth
ROE of 22,14% indicates high profitability
Generating 1,51B in free cash flow
Capital efficient — spends only 2,34% of revenue on capex
Groei
Revenue Growth (5Y)
4,07%
Revenue (1Y)4,84%
Earnings (1Y)4,57%
FCF Growth (3Y)-6,26%
Kwaliteit
Return on Equity
22,14%
ROIC10,16%
Net Margin10,10%
Op. Margin13,39%
Veiligheid
Debt / Equity
0,96
Current Ratio1,18
Interest Coverage6,14
Waardering
P/E Ratio
15,52
P/B Ratio3,12
EV/EBITDA13,70
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,84% | Revenue Growth (3Y) | 2,71% |
| Earnings Growth (1Y) | 4,57% | Earnings Growth (3Y) | 15,29% |
| Revenue Growth (5Y) | 4,07% | Earnings Growth (5Y) | -1,87% |
| Profitability | |||
| Revenue (TTM) | 20,63B | Net Income (TTM) | 2,08B |
| ROE | 22,14% | ROA | 5,65% |
| Gross Margin | 39,99% | Operating Margin | 13,39% |
| Net Margin | 10,10% | Free Cash Flow (TTM) | 1,51B |
| ROIC | 10,16% | FCF Growth (3Y) | -6,26% |
| Safety | |||
| Debt / Equity | 0,96 | Current Ratio | 1,18 |
| Interest Coverage | 6,14 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 15,52 | P/B Ratio | 3,12 |
| P/S Ratio | 1,57 | PEG Ratio | 4,13 |
| EV/EBITDA | 13,70 | Dividend Yield | 0,00% |
| Market Cap | 32,34B | Enterprise Value | 37,83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20,63B | 19,67B | 19,55B | 18,34B | 17,59B |
| Net Income | 2,08B | 1,99B | 1,57B | 1,92B | 2,25B |
| EPS (Diluted) | 4,55 | 4,34 | 3,02 | 4,22 | 4,90 |
| Gross Profit | 8,25B | 8,21B | 7,92B | 7,18B | 7,17B |
| Operating Income | 2,76B | 2,63B | 2,44B | 2,52B | 2,80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36,91B | 33,09B | 32,45B | 27,54B | 26,31B |
| Total Liabilities | 26,31B | 24,44B | 25,14B | 17,95B | 9,41B |
| Shareholders' Equity | 10,38B | 8,45B | 7,13B | 9,36B | 16,66B |
| Total Debt | 10,00B | 9,38B | 9,86B | 8,64B | 437,00M |
| Cash & Equivalents | 4,51B | 2,89B | 2,50B | 1,45B | 556,00M |
| Current Assets | 10,70B | 9,52B | 9,01B | 7,82B | 6,54B |
| Current Liabilities | 9,11B | 9,55B | 8,98B | 7,19B | 6,76B |